Medtronic plc (MDT) : Currently there are 15 street experts covering Medtronic plc (MDT) stock. The most bullish and bearish price target for the stock is $104 and $56 respectively for the short term. The average price target of all the analysts comes to $90.83. The estimated standard deviation from the target is $11.4.
Medtronic plc (MDT) : 12 brokerage houses believe that Medtronic plc (MDT) is a Strong Buy at current levels. 2 Analyst considers the fundamentals to be worthy of a Buy recommendation. 5 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Medtronic plc (MDT). Zacks Investment Research suggests a Hold with a rank of 3. 1 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 20 Wall Street Analysts endorse the stock as a Buy with a rating of 1.78.
Also, Equity Analysts at the Jefferies maintains the rating on Medtronic plc (NYSE:MDT). The brokerage firm has issued a Buy rating on the shares. The Analysts at the ratings agency raises the price target from $93 per share to $100 per share. The rating by the firm was issued on August 26, 2016.
Medtronic plc (NYSE:MDT): The stock opened at $87.09 on Thursday but the bulls could not build on the opening and the stock topped out at $87.21 for the day. The stock traded down to $86.32 during the day, due to lack of any buying support eventually closed down at $86.98 with a loss of -0.06% for the day. The stock had closed at $87.03 on the previous day. The total traded volume was 3,116,760 shares.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.